Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-02 · accession 0001104659-26-022440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-03-02 | RYTM | Smith Hunter C | CFO | M - OptEx | $6.80 | +6,099 | 116.6K | +6% | +$41.5K |
| D | 2026-03-02 | 2026-03-02 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -6,099 | 91.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | M | A | 6,099 | $6.80 | 116,611 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2026-03-02 | M | D | 6,099 | $0.00 | 91,401 | D | $6.80 · — to 2032-02-08 | 6,099 Common Stock | (F1) The options are fully vested. |